Cencora | COR - Gross Profit On Sales

Stock Price
261.87
Daily Change
4.16 1.61%
Monthly
-18.93%
Yearly
-10.51%
Q2 Forecast
252.53

Cencora reported $2.99B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Ambu A/S DKK 948M 1000K Mar/2026
Amplifon EUR 890.64M 787.47M Dec/2025
Apollo Hospitals Enterprise Ltd INR 30.95B 4.31B Dec/2025
Avanos Medical USD 94.2M 8.2M Mar/2026
Brookdale Senior Living USD 210.85M 7.15M Sep/2025
Cencora USD 2.99B 31.87M Dec/2025
Coloplast 4.74B 27M Dec/2025
Convatec Group USD 660.5M 348.95M Dec/2024
Diasorin EUR 186M 0 Mar/2026
Encompass Health USD 1.48B 67.2M Dec/2025
Enovis USD 365.48M 16.06M Mar/2026
GE HealthCare Technologies USD 2.26B 272M Dec/2025
Gulf Medical Proj AED 46.22M 8.48M Mar/2025
Hoya 209.21B 147.26B Mar/2026
Med Life RON 628.26M 7.99M Sep/2025
Oriola-kd EUR 40.2M 2.1M Sep/2025
Pediatrix Medical Group 125.98M 366.89M Dec/2025
Rede D'or Sao Luiz BRL 3.22B 34.56M Mar/2026
Siemens Healthineers EUR 2.14B 66M Mar/2026
Solventum Corp USD 1.1B 70M Mar/2026
Sonova Holding CHF 1.28B 205.2M Dec/2025
Supermax Corporation Bhd MYR -143.15M 161.11M Sep/2025
Veradigm USD 83.44M 3.95M Sep/2022
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025